COMPUMEDICS LIMITED — Capital/Financing Update 2014

Dec 21, 2014

==> picture [80 x 77] intentionally omitted <==

ASX Announcement 22[nd] December 2014

New Funding Arrangements Leverage Compumedics into Key Export Markets

• New additional export working capital facility for USD1.0m executed with Export Finance and Insurance Corporation (EFIC) in conjunction with ANZ Bank

• Further strengthens Company’s ability to meet growing off-­‐shore demand for its products in key export markets around the world, including new initiatives in eHealth

• Declining Australian Dollar provides ideal window to grow exports

• Enhanced production and employment capability as export competitiveness improves

Compumedics Limited (ASX: CMP) is pleased to announce it has executed a new export working capital guarantee facility with EFIC in conjunction with the ANZ Bank. This new facility will provide funding of up to USD1.0m to enable the Company to continue to grow and develop its key export markets.

The facility is complementary to Compumedics existing working capital facilities.

As such the new funding will underpin the future growth of the Company in key export markets by providing working capital to enable production to remain in front of demand.

As the Company has indicated, via its announcements to the Australian Securities

Exchange (ASX) over the course of 2014, it remains focused on not only growing its core sleep diagnostic and neurological monitoring businesses but continues to pursue growth opportunities in eHealth, particularly as it relates to the sleep monitoring and diagnosis market.

This facility, together with the declining Australian Dollar to the USD dollar provides an excellent opportunity for the Company to continue to grow its exports, provide a diversified range of employment opportunities locally and continue to pursue the eHealth growth initiatives.

**In

commenting on this important financing milestone, Executive Chairman & CEO, Dr David Burton said,**

“Compumedics has worked diligently over recent time to restore profitability and establish the necessary working capital arrangements to ensure the Company can harness the commercial opportunities in front of it. This new EFIC facility will, in conjunction with the Company’s existing funding arrangements, enable the Company to continue to deliver strong export revenues and business to Australia, as it has done so for more than two decades.”

“Importantly the Company will be in a position to pursue existing and future growth opportunities in key offshore markets, including eHealth and growth in our traditional US, Asian and European markets, with the resultant opportunities this creates locally for employment and support services and activities. The Company will continue to up-­‐date the market on these initiatives as relevant commercial milestones are met.”

**About

Compumedics Limited**

Compumedics Limited (ASX: CMP) is a medical device company involved in the development, manufacture and commercialisation of diagnostics technology for the sleep, brain and ultrasonic blood-­‐flow monitoring applications. The Company owns US based Neuroscan and Germany basedDWL Elektronishe GmbH. In conjunction with these two subsidiaries, Compumedics has a broad international reach, including Americas; Australia and Asia Pacific; and Europe and the Middle East.

Executive Chairman, Dr David Burton, founded Compumedics in 1987. In the same year the Company successfully designed and installed the first Australian, fully computerised Sleep Clinic at Epworth Hospital in Melbourne. Following this early success, Compumedics focused on the development of products that sold into the growing international sleep clinic and home monitoring markets. Compumedics listed on the Australian Securities Exchange in 2000. Over the years, Compumedics has received numerous awards and accolades including Australia’s exporter of the year and has been recognised as a Top 100 Innovator by both German and Australian Governments.

**For

further information please contact:**

Dr David Burton , Executive Chairman, CEO Compumedics Limited T: + 61 3 8420 7300, F: +61 3 8420 7399 For investor relations and media enquiries please

Mr David Lawson , Executive Director, CFO Compumedics Limited T: + 61 3 8420 7300, F: +61 3 8420 7399

Rod North , Managing Director, Bourse Communications Pty Ltd T: (03) 9510 8309, M: 0408 670 706 E: rod@boursecommunications.com.au